Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

High-dose ifosfamide with mesna uroprotection: a phase I study.

High-dose ifosfamide with mesna uroprotection: a phase I study. J Clin Oncol. 1990 Jan; 8(1):170-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.